Twitter | Search | |
Salim R. Rezaie
EM/IM Doc; Founder of REBEL EM & REBEL Cast; Viva (Tweets are opinion only)
15,933
Tweets
377
Following
16,555
Followers
Tweets
Salim R. Rezaie retweeted
Stephen Rahm 13h
EM 2019 - gonna be an awesome one! ⁦
Reply Retweet Like
Salim R. Rezaie retweeted
ashley liebig Sep 22
had a blast at so we wrote about it.
Reply Retweet Like
Salim R. Rezaie Sep 22
Reply Retweet Like
Salim R. Rezaie retweeted
Dr. Jaime Hope Sep 21
So excited to be a part of this AMAZING conference with outstanding educators like and my girl
Reply Retweet Like
Salim R. Rezaie Sep 21
IV Fluid Choice Part 3: The SALT-ED Trial via
Reply Retweet Like
Salim R. Rezaie Sep 20
Great question but important to realize each of us is at a different point in the spectrum of medical education/learning and has different strengths/weaknesses...all we can do is try to be better than we were the day before (ie aggregation of marginal gains) HT
Reply Retweet Like
Salim R. Rezaie Sep 20
So Many Great Sessions Scheduled for Rebellion in EM 2019 | June 28th - 30th, 2019 | San Antonio, TX | Ob/Gyn Emergencies by the amazing &
Reply Retweet Like
Salim R. Rezaie retweeted
Ken Milne Sep 20
<4.5 hours: potentially alteplase (tPA) eligible (Evidence Level A) Eddy - how is this a Level A recommendation? Only one RCT showing benefit from 3-4.5hrs
Reply Retweet Like
Salim R. Rezaie Sep 20
LMWH in Cancer-Related VTE (CLOT Study) via
Reply Retweet Like
Salim R. Rezaie Sep 19
Unfortunately a quick in and out trip...already back in TX
Reply Retweet Like
Salim R. Rezaie retweeted
ALLOhioEM Sep 19
The conference page for is now updated! Be sure to visit for details and to register!
Reply Retweet Like
Salim R. Rezaie Sep 19
Bug Juice Potpourri via 1. In pts w/ isolated cellulitis w/o MRSA risk factors, prescribe streptococci monotherapy 2. Pts with uncomplicated SSTI + dc home should not receive IV Vanc
Reply Retweet Like
Salim R. Rezaie Sep 19
Intranasal Analgesics: What's Your Pick? - Part 1 via
Reply Retweet Like
Salim R. Rezaie Sep 19
EMCrit Failed Airway Algorithm 2018 from ResusTO via
Reply Retweet Like
Salim R. Rezaie retweeted
Michael Weinstock Sep 19
Reply Retweet Like
Salim R. Rezaie Sep 19
IV Fluids Part 2: The SMART Trial via NS mostly safe (at least in small vol), but due to methodologic concerns of SMART, difficult to extrapolate results to large vol crystalloid resus (Physiologic issues w/ NS may be more relevant)
Reply Retweet Like
Salim R. Rezaie Sep 19
NODE-1 Trial: Nasal Spray Calcium Channel Blocker for SVT via Not Ready for Primetime, but Interesting
Reply Retweet Like
Salim R. Rezaie Sep 19
Replying to @K_ScottMD @UPennEM
TY for having me...great group...the future of EM is very bright
Reply Retweet Like
Salim R. Rezaie retweeted
AdenaEM Sep 19
Want to interact with some of the leaders in EM education? Join us at for a live chat with Rob Orman, Ryan Radecki, , & on 9/26/18 during the Adena Chest Pain Summit!
Reply Retweet Like
Salim R. Rezaie Sep 18
TnI Elevation in Non-Cardiac Critical Illness via 1. Type 1 MI = Plaque Rupture; Type 2 MI = Demand Ischemia 2. OASIS-5 Trial -> Fondaparinux 2.5mg = DVT prophylaxis & ACS Tx (2 birds with 1 stone)
Reply Retweet Like